Search

The Ecosystem: Oxford accelerator proposes a new model for commercialising rare disease therapies

Forty new rare disease programmes entering the clinic over the next decade. This is the goal of a new collaboration between Oxford University and the Harrington Discovery Institute, which aims to put up to £200M into getting projects out academic labs and into clinical development  

Widening newsletter 20: As Hungary moves to unlock EU Cohesion money, the Horizon Europe impasse continues

This week we are taking a close look at the ongoing stand-off between Hungary and the European Commission over Horizon Europe funding, and how angel investors in central and eastern Europe are keeping an upbeat perspective on deep-tech in the region.

We also have a guest opinion piece on what eastern Europe can learn from Portugal’s sustained effort in R&D policy and funding, and a report from a Science|Business conference in Prague last week.